FXR2

FXR2 is a cytoplasmic, KH-domain RNA-binding protein that controls neuronal mRNA metabolism and central nervous system function as part of the Fragile X-related protein family (PMID:7489725, PMID:11875043). It physically associates with FMRP (FMR1) and FXR1 to form homo- and heteromers and co-sediments with the 60S ribosomal subunit, placing it at the translational machinery in differentiated neurons (PMID:7489725, PMID:9259278). Mechanistically, FXR2 binds and destabilizes specific target mRNAs: it reduces the stability of Noggin mRNA, thereby sustaining BMP signaling and constraining proliferation and fate specification of neural stem/progenitor cells in the adult dentate gyrus (PMID:21658585). In vivo, Fxr2 loss produces hyperactivity, impaired sensorimotor gating, and deficits in spatial learning and contextual fear, and Fxr2 interacts genetically with Fmr1, with combined loss yielding exaggerated behavioral phenotypes—establishing cooperative control of locomotion, gating, and cognition (PMID:11875043, PMID:16675531). Structurally, its N-terminal tandem Tudor domains adopt a UHRF1-like architecture that encodes a non-canonical nuclear localization signal and selectively recognizes trimethylated peptides (PMID:21072162). FXR2 transcription is driven by a bidirectional promoter bound and activated by NF-YA, AP2, Nrf1, and Sp1 (PMID:16886907).

1. 1995 High

   Established FXR2 as a member of the Fragile X-related family by showing it physically partners with FMRP and FXR1 and itself binds RNA, defining the molecular context in which it acts.

   Evidence Reciprocal co-immunoprecipitation in vivo and in vitro, RNA-binding assay, and subcellular localization

   PMID:7489725

   Open questions at the time

   • Did not identify specific RNA targets
   • Functional consequence of heteromer formation not defined
2. 1997 Medium

   Linked FXR2 to the translational apparatus and to specific neurons, suggesting a role in neuronal mRNA handling that is partly independent of FMR1/FXR1.

   Evidence Ribosome sedimentation/subcellular fractionation and immunohistochemistry in adult brain

   PMID:9259278

   Open questions at the time

   • Whether ribosome association reflects active translational regulation not shown
   • Independent functions inferred from expression pattern, not tested directly
3. 2002 High

   Demonstrated that FXR2 is required in vivo for CNS function, moving the protein from a biochemical interactor to a physiological regulator of behavior.

   Evidence Fxr2 knockout mice subjected to a behavioral test battery

   PMID:11875043

   Open questions at the time

   • Molecular targets underlying behavioral deficits not identified
   • Cell types and circuits responsible not resolved
4. 2006 High

   Showed that FXR2 and FMR1 act cooperatively in shared behavioral pathways, indicating functional overlap within the family beyond simple physical interaction.

   Evidence Fmr1/Fxr2 double knockout mice with behavioral epistasis analysis

   PMID:16675531

   Open questions at the time

   • Shared molecular targets driving epistasis unknown
   • Whether cooperation occurs at the level of mRNA binding not addressed
5. 2006 High

   Defined the transcriptional control of FXR2, identifying activators and a bidirectional promoter architecture.

   Evidence EMSA, ChIP, dominant-negative co-transfection, and luciferase reporter assays in neuronal and muscle cells

   PMID:16886907

   Open questions at the time

   • Identity of the gene transcribed from the opposite promoter direction not characterized in this dataset
   • Regulation of FXR2 expression in disease states not addressed
6. 2010 High

   Provided atomic-level insight into FXR2 domains, revealing a UHRF1-like tandem Tudor module that reads trimethylated peptides and harbors a non-canonical NLS.

   Evidence X-ray crystallography at 1.92 Å with biochemical peptide-binding assays

   PMID:21072162

   Open questions at the time

   • Physiological trimethylated ligand not identified
   • Functional role of the non-canonical NLS in cells not tested
7. 2011 High

   Defined a concrete molecular mechanism: FXR2 destabilizes Noggin mRNA to set BMP signaling levels and thereby control adult dentate gyrus neurogenesis.

   Evidence Fxr2 knockout mice with mRNA stability assays, BMP pathway analysis, and region-specific neural stem/progenitor proliferation and fate assays

   PMID:21658585

   Open questions at the time

   • Whether other target mRNAs contribute not established
   • Mechanism by which FXR2 binding triggers destabilization unknown
8. 2006 Medium

   Captured a disease-associated p53/FXR2 fusion, incidentally indicating wild-type FXR2 localizes at the nuclear periphery in this cell context.

   Evidence Western blot, immunofluorescence of FLAG-tagged constructs, and transactivation reporter assay in leukemia cells

   PMID:16778363

   Open questions at the time

   • Single cell-line observation
   • Relevance of nuclear-periphery localization to normal FXR2 function unclear
9. 2019 Medium

   Refined the FXR2–FMR1 genetic relationship, showing partial FXR2 reduction modulates Fmr1 KO phenotypes in a context-dependent, sometimes opposing manner.

   Evidence Fmr1 KO/Fxr2 heterozygous double-mutant mice with behavioral battery

   PMID:30654445

   Open questions at the time

   • Mechanism of the paradoxical social-behavior reversal unknown
   • Dosage-dependent molecular effects not defined
10. 2025 Low

    Proposed new molecular roles for FXR2 as an m6A reader and as a guardian of nuclear transport and stress granule homeostasis, extending its function beyond cytoplasmic mRNA destabilization.

    Evidence m6A RNA pull-down and transcriptome-wide RBP mapping with hESC differentiation assays; FXR2 knockout HAP1 cells with nuclear pore, nucleocytoplasmic transport, TDP-43, and stress granule assays (both preprints)

    Open questions at the time

    • Preprint, single lab, not independently confirmed
    • Direct molecular link between FXR2 and nuclear pore integrity not established
    • m6A-binding determinants on FXR2 not mapped

• The full repertoire of FXR2 target mRNAs and the biochemical mechanism connecting its RNA binding, ribosome association, Tudor-mediated methyl-peptide reading, and proposed m6A/nuclear-transport roles into one pathway remains unresolved.
• No genome-wide validated target set in neurons
• Link between Tudor methyl-reading and mRNA regulation unknown
• m6A reader and nuclear-transport roles await peer-reviewed confirmation